Blundell Biotech is a U.S.-based biotechnology company with operations and earnings in a number of foreign countries. The company's profits by subsidiary, in local currency (in millions), are shown in the following table for 2013 and 2014. Japanese Subsidiary British Subsidiary Net Income United European Chinese Russian States Subsidiary Subsidiary Subsidiary Subsidiary RUB USD EUR 204.00 CNY 168.00 124.00 360.00 RUB USD EUR 208.00 CNY 194.00 116.000 382.00 2013 JPY 1,5001 GBP 100.000 2014 JPY 1,4601 GBP 106.401 The average exchange rate for each year, by currency pairs, was the following. Use this data to answer the following questions. Exchange Rate JPY-1 USD USD - 1 GBP USD - 1 EUR CNY-1 USD RUB-1 USD USD 2013 97.57 1.56461 1.32861 6.1484 31.86 1.0000 2014 105.881 1.6473 1.3288 6.1612 38.62 1.00001 a. What was Blundell Biotech's consolidated profits in U.S. dollars in 2013 and 2014? b. If the same exchange rates were used for both years - what is often called a "constant currency basis" - was the change in corporate earnings on a constant currency basis? c. Using the results of the constant currency analysis in part b, is it possible to separate Blundell's growth in earnings between local currency earnings and foreign exchange rate impacts on a consolidated basis